Target tumor microenvironment by innate T cells
The immunosuppressive tumor microenvironment (TME) remains one of the most prevailing barriers obstructing the implementation of effective immunotherapy against solid-state cancers. Eminently composed of immunosuppressive tumor associated macrophages (TAMs) and myeloid-derived suppressor cells (MDSC...
| Published in: | Frontiers in Immunology |
|---|---|
| Main Authors: | Yan-Ruide Li, Matthew Wilson, Lili Yang |
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-10-01
|
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.999549/full |
Similar Items
Editorial: Exploring unconventional T cells and CAR-T-cells in cancer immunotherapy
by: Laura Patrussi, et al.
Published: (2026-06-01)
by: Laura Patrussi, et al.
Published: (2026-06-01)
Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies
by: Yan-Ruide Li, et al.
Published: (2023-10-01)
by: Yan-Ruide Li, et al.
Published: (2023-10-01)
Die Kämpfe únd schláchten—the struggles and battles of innate-like effector T lymphocytes with microbes
by: Sebastian Joyce, et al.
Published: (2023-04-01)
by: Sebastian Joyce, et al.
Published: (2023-04-01)
Research progress in immune cells regulating drug resistance of tumor cells in tumor microenvironment
by: ZHANG Yesheng, et al.
Published: (2024-07-01)
by: ZHANG Yesheng, et al.
Published: (2024-07-01)
Description of invariant NKT cells.
by: Katarzyna Karwicka, et al.
Published: (2021-09-01)
by: Katarzyna Karwicka, et al.
Published: (2021-09-01)
Re-education of the Tumor Microenvironment With Targeted Therapies and Immunotherapies
by: Shin Foong Ngiow, et al.
Published: (2020-07-01)
by: Shin Foong Ngiow, et al.
Published: (2020-07-01)
Innate immune cell activation after HIV-1 vaccine administration is associated with increased antibody production
by: Kombo F. N’guessan, et al.
Published: (2024-02-01)
by: Kombo F. N’guessan, et al.
Published: (2024-02-01)
Role of innate T cells in anti-bacterial immunity
by: Yifang eGao, et al.
Published: (2015-06-01)
by: Yifang eGao, et al.
Published: (2015-06-01)
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
by: Antonino Glaviano, et al.
Published: (2025-01-01)
by: Antonino Glaviano, et al.
Published: (2025-01-01)
Profiling of innate and adaptive immune cells during influenza virus infection reveals sex bias in invariant natural killer T (iNKT) cells
by: Piotr Humeniuk, et al.
Published: (2023-04-01)
by: Piotr Humeniuk, et al.
Published: (2023-04-01)
Exploring the role of unconventional T cells in rheumatoid arthritis
by: Tangqing Xu, et al.
Published: (2025-08-01)
by: Tangqing Xu, et al.
Published: (2025-08-01)
Innate iNKT cells: from biological insight to clinical impact
by: Antonia Rotolo, et al.
Published: (2025-09-01)
by: Antonia Rotolo, et al.
Published: (2025-09-01)
Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression
by: Dorian Stolk, et al.
Published: (2018-09-01)
by: Dorian Stolk, et al.
Published: (2018-09-01)
Cord blood innate-like T cell responses in neonates born to healthy women and women living with HIV
by: David Rach, et al.
Published: (2025-08-01)
by: David Rach, et al.
Published: (2025-08-01)
Editorial: Therapeutic potential of innate and innate-like effector lymphocytes in autoimmune and inflammatory diseases
by: Lan Wu, et al.
Published: (2023-10-01)
by: Lan Wu, et al.
Published: (2023-10-01)
Editorial: Adaptive immune regulation of non-alcoholic steatohepatitis (NASH)
by: Haiguang Wang, et al.
Published: (2026-04-01)
by: Haiguang Wang, et al.
Published: (2026-04-01)
Strategies to overcome myeloid cell induced immune suppression in the tumor microenvironment
by: Jennifer Cao, et al.
Published: (2023-04-01)
by: Jennifer Cao, et al.
Published: (2023-04-01)
Leukocyte Imbalances in Mucopolysaccharidoses Patients
by: Nuno Lopes, et al.
Published: (2023-06-01)
by: Nuno Lopes, et al.
Published: (2023-06-01)
It Takes “Guts” to Cause Joint Inflammation: Role of Innate-Like T Cells
by: Céline Mortier, et al.
Published: (2018-06-01)
by: Céline Mortier, et al.
Published: (2018-06-01)
Interactions between glioblastoma and myeloid cells
by: Yuting Li, et al.
Published: (2025-06-01)
by: Yuting Li, et al.
Published: (2025-06-01)
Tumor-Associated Macrophages: Protumoral Macrophages in Inflammatory Tumor Microenvironment
by: Somaiyeh Malekghasemi, et al.
Published: (2020-08-01)
by: Somaiyeh Malekghasemi, et al.
Published: (2020-08-01)
The immune suppressive tumor microenvironment in multiple myeloma: The contribution of myeloid-derived suppressor cells
by: Claudia Giannotta, et al.
Published: (2023-01-01)
by: Claudia Giannotta, et al.
Published: (2023-01-01)
MAIT and iNKT cells in tissue homeostasis and repair
by: Rafael Almeida Paiva, et al.
Published: (2025-05-01)
by: Rafael Almeida Paiva, et al.
Published: (2025-05-01)
The Role of CD1d and MR1 Restricted T Cells in the Liver
by: Wenyong Huang, et al.
Published: (2018-10-01)
by: Wenyong Huang, et al.
Published: (2018-10-01)
RNAseq of INOCA patients identifies innate, invariant, and acquired immune changes: potential autoimmune microvascular dysfunction
by: Kevin Jaatinen, et al.
Published: (2024-06-01)
by: Kevin Jaatinen, et al.
Published: (2024-06-01)
CD8+ T-cell immunity orchestrated by iNKT cells
by: Yingyu Qin, et al.
Published: (2023-01-01)
by: Yingyu Qin, et al.
Published: (2023-01-01)
The role of mucosal associated invariant T cells in antimicrobial immunity
by: Ruth J Napier, et al.
Published: (2015-07-01)
by: Ruth J Napier, et al.
Published: (2015-07-01)
A brief review of clinical trials involving manipulation of invariant NKT cells as a promising approach in future cancer therapies
by: Małgorzata Waldowska, et al.
Published: (2017-08-01)
by: Małgorzata Waldowska, et al.
Published: (2017-08-01)
Deficiency of innate-like T lymphocytes in chronic obstructive pulmonary disease
by: Mariann Szabó, et al.
Published: (2017-11-01)
by: Mariann Szabó, et al.
Published: (2017-11-01)
Distinct Dysfunctional States of Circulating Innate-Like T Cells in Metabolic Disease
by: Yanyan Li, et al.
Published: (2020-03-01)
by: Yanyan Li, et al.
Published: (2020-03-01)
Anti-HBV treatment partially restores the dysfunction of innate immune cells and unconventional T cells during chronic HBV infection
by: Yiwen Shu, et al.
Published: (2025-07-01)
by: Yiwen Shu, et al.
Published: (2025-07-01)
Dysregulation of innate cell types in the hepatic immune microenvironment of alcoholic liver cirrhosis
by: Ao Ren, et al.
Published: (2023-02-01)
by: Ao Ren, et al.
Published: (2023-02-01)
An Ex Vivo 3D Tumor Microenvironment-Mimicry Culture to Study TAM Modulation of Cancer Immunotherapy
by: Yan-Ruide Li, et al.
Published: (2022-05-01)
by: Yan-Ruide Li, et al.
Published: (2022-05-01)
Role of innate T cells in necrotizing enterocolitis
by: Jianyun Liu, et al.
Published: (2024-02-01)
by: Jianyun Liu, et al.
Published: (2024-02-01)
A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment
by: Francesca Hofer, et al.
Published: (2021-10-01)
by: Francesca Hofer, et al.
Published: (2021-10-01)
The effector function of mucosal associated invariant T cells alters with aging and is regulated by RORγt
by: Zhi Yang, et al.
Published: (2024-11-01)
by: Zhi Yang, et al.
Published: (2024-11-01)
Using Single Cell Transcriptomics to Elucidate the Myeloid Compartment in Pancreatic Cancer
by: Padma Kadiyala, et al.
Published: (2022-05-01)
by: Padma Kadiyala, et al.
Published: (2022-05-01)
Harnessing innate immunity against glioblastoma microenvironment
by: Wenbo Zhang, et al.
Published: (2025-07-01)
by: Wenbo Zhang, et al.
Published: (2025-07-01)
Research progress on the role of immune cells in the tumor microenvironment in the development and progression of oral squamous cell carcinoma
by: LIAO Xinyue, FENG Yan, YU Li
Published: (2025-02-01)
by: LIAO Xinyue, FENG Yan, YU Li
Published: (2025-02-01)
Insights Into Mucosal-Associated Invariant T Cell Biology From Studies of Invariant Natural Killer T Cells
by: Lucy C. Garner, et al.
Published: (2018-06-01)
by: Lucy C. Garner, et al.
Published: (2018-06-01)
Similar Items
-
Editorial: Exploring unconventional T cells and CAR-T-cells in cancer immunotherapy
by: Laura Patrussi, et al.
Published: (2026-06-01) -
Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies
by: Yan-Ruide Li, et al.
Published: (2023-10-01) -
Die Kämpfe únd schláchten—the struggles and battles of innate-like effector T lymphocytes with microbes
by: Sebastian Joyce, et al.
Published: (2023-04-01) -
Research progress in immune cells regulating drug resistance of tumor cells in tumor microenvironment
by: ZHANG Yesheng, et al.
Published: (2024-07-01) -
Description of invariant NKT cells.
by: Katarzyna Karwicka, et al.
Published: (2021-09-01)
